The findings of the latest AIB manufacturing survey

episode

Breakfast Business with Joe Lynam not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Breakfast Business with Joe Lynam

K-shaped economy 6 min · 23 Dec 2025

Medtech firm secures funding to support its push for US regulatory clearance 8 min · 23 Dec 2025

Tuesday's business headlines 3 min · 23 Dec 2025

Volatile Geopolitics the New Norm 7 min · 22 Dec 2025

Monday's business headlines 9 min · 22 Dec 2025

A positive picture for the domestic economy 7 min · 19 Dec 2025

All episodes from Breakfast Business with Joe Lynam →

Report any issue

Source

Recorded01 Nov 2023

Publisherrss.podplaystudio.com

Handlerec:9175301

Show notes

The lion's share of manufacturing in this country stems from the pharmaceutical sector. But huge exporters such as Pfizer are now seeing a clear decline in sales as demand for the COVID vaccine drops, that’s having a direct impact on our manufacturing data and has been reflected in the latest AIB survey. Oliver Mangan the Chief Economist from AIB joined Joe this morning.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in